Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Intra-Cellular Therapies Inc. (ITCI)

« Back to company index

ITCI Chatter Timeline

Stock Ticker for ITCI

Most Active Tweeters for ITCI

UserTweets
@HealthcareBeat 10
@Tickeron 9
@dispatchtribune 7
@gcassidy718 7
@dakotafinancial 6

Recent Tweets for ITCI

gcassidy718 @gcassidy718
$ITCI waiting for the turn around . . . -3.89 % change recently https://t.co/pg77CdHU2e
7:07pm
BlueBioNow @BlueBioNow
$ITCI good earnings are hopefully coming next quarter -3.89 % change recently https://t.co/fSwQakjS1N
1:07pm
BlueBioNow @BlueBioNow
$ITCI "Everything is impossible until someone does it" -3.89 % change recently https://t.co/fSwQakjS1N
1:07am
gcassidy718 @gcassidy718
$ITCI Valuation is starting to make more sense now $21.79. https://t.co/pg77CdHU2e
12:07am
InsiderAlerts4U @InsiderAlerts4U
$ITCI: New Insider Filing on Intra-Cellular Therapies, Inc.'s Director RORY B RIGGS: https://t.co/13JIekd67s
July 3rd 2020, 7:07pm
Tickeron @Tickeron
$ITCI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/49WQveyuap
July 3rd 2020, 6:07pm
BlueBioNow @BlueBioNow
$ITCI a bit volatility -3.89 % change recently https://t.co/fSwQakjS1N
July 3rd 2020, 2:07pm
gcassidy718 @gcassidy718
$ITCI I'd like to make an exit, just not now -3.89 % change recently https://t.co/pg77CdHU2e
July 3rd 2020, 5:07am
HealthcareBeat @HealthcareBeat
$15,735.71 of shares acquired by Alafi Christopher D (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/1Pqq0o5ME7
July 3rd 2020, 1:07am
InsiderAlerts4U @InsiderAlerts4U
$ITCI: New Insider Filing on Intra-Cellular Therapies, Inc.'s Director CHRISTOPHER D ALAFI: https://t.co/fdQ2pK32N7
July 3rd 2020, 1:07am
HealthcareBeat @HealthcareBeat
$15,735.71 of shares acquired by Riggs Rory B (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/mxGnsMZOKX
July 3rd 2020, 12:07am
HealthcareBeat @HealthcareBeat
$14,991.28 of shares acquired by Lerner Richard A (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/KKQezkppvR
July 3rd 2020, 12:07am
HealthcareBeat @HealthcareBeat
$7,059.25 of shares acquired by Van Nostrand Robert L (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/uu5utrXKLb
July 3rd 2020, 12:07am
InsiderAlerts4U @InsiderAlerts4U
$ITCI: New Insider Filing on Intra-Cellular Therapies, Inc.'s Director RICHARD A LERNER: https://t.co/SRXgmaZXnF
July 2nd 2020, 9:07pm
Tickeron @Tickeron
$ITCI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/t9PWwxNZA0
July 2nd 2020, 4:07pm
deus_trader @deus_trader
Optimus Maximus v2 2020-07-02 16:01 ET. *Closed/Covered previously shorted: $ITCI at $24.23 for 0.90 profit (3.58%)… https://t.co/r7LhT4kiOC
July 2nd 2020, 4:07pm
Tickeron @Tickeron
$ITCI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/M0zrEmPICO
July 1st 2020, 4:07pm
deus_trader @deus_trader
Optimus Maximus v2 2020-07-01 09:32 ET. *Closed/Covered previously shorted: $ITCI at $25.19 for 0.25 loss (-1.02%).… https://t.co/Vx7Je5JYcA
July 1st 2020, 9:07am
EnterpriseLeade @EnterpriseLeade
Intra-Cellular Therapies Inc $ITCI Expected to Post Earnings of -$0.98 Per Share https://t.co/D8hJZHoPma
July 1st 2020, 7:07am
dailypoliticaln @dailypoliticaln
Intra-Cellular Therapies Inc $ITCI Expected to Post Earnings of -$0.98 Per Share https://t.co/va3QON97Vn
July 1st 2020, 7:07am
ZolmaxNews @ZolmaxNews
Intra-Cellular Therapies Inc $ITCI Expected to Post Earnings of -$0.98 Per Share https://t.co/Sq2fCPPi93
July 1st 2020, 7:07am
GiovanniMotta2 @GiovanniMotta2
$ITCI should go to 30+$ in the next few weeks considering also Intra-Cellular Therapies Announces Positive Top-line… https://t.co/CTx5hdNvIW
July 1st 2020, 6:07am
deus_trader @deus_trader
Optimus Maximus v2 2020-06-30 10:29 ET. Shorted/Opened: $ITCI at $25.00. Intra-Cellular Therapies, Inc (CORP). Win… https://t.co/55VlDLz3vJ
June 30th 2020, 10:06am
deus_trader @deus_trader
Optimus Maximus v2 2020-06-30 10:01 ET. Shorted/Opened: $ITCI at $25.20. Intra-Cellular Therapies, Inc (CORP). Win… https://t.co/cAxZ3UxEU2
June 30th 2020, 10:06am
dailypoliticaln @dailypoliticaln
Brokerages Expect Intra-Cellular Therapies Inc $ITCI Will Announce Quarterly Sales of $3.10 Million https://t.co/2KhaYzI5Lj
June 30th 2020, 2:06am
ZolmaxNews @ZolmaxNews
Intra-Cellular Therapies Inc $ITCI Expected to Announce Quarterly Sales of $3.10 Million https://t.co/It18YbS9t2
June 30th 2020, 2:06am
gcassidy718 @gcassidy718
$ITCI That's rough. . . -2.53 % change recently https://t.co/pg77CdHU2e
June 30th 2020, 1:06am
Gambiste1 @Gambiste1
RT @MaisaCorp: $ITCI its phase 1/2 study on novel inhibitor ITI-214-104 for the treatment of patients with chronic systolic heart failure w…
June 29th 2020, 7:06pm
Gambiste1 @Gambiste1
RT @syinvesting: $ITCI Intra-Cellular Therapies announced positive topline Phase 1/2 SAD data from ITI-214 (PDE1 inhibitor) in patients wit…
June 29th 2020, 7:06pm
MaisaCorp @MaisaCorp
$ITCI its phase 1/2 study on novel inhibitor ITI-214-104 for the treatment of patients with chronic systolic heart… https://t.co/xdOJKGdaYl
June 29th 2020, 4:06pm
syinvesting @syinvesting
$ITCI Intra-Cellular Therapies announced positive topline Phase 1/2 SAD data from ITI-214 (PDE1 inhibitor) in patie… https://t.co/lqwZwkt0nJ
June 29th 2020, 3:06pm
bucksneuro @bucksneuro
RT @BillMiller32: @alsterbrown Thanks! I added on the brief sub-$25 pull-back here $ITCI
June 29th 2020, 12:06pm
SlingshotCtlyst @SlingshotCtlyst
Top-line Results from $ITCI ITI-214 Phase I/II Study in Patients with Heart Failure available here: https://t.co/QGAYCCXsUB
June 29th 2020, 10:06am
BillMiller32 @BillMiller32
@alsterbrown Thanks! I added on the brief sub-$25 pull-back here $ITCI
June 29th 2020, 10:06am
Briefingcom @Briefingcom
$ITCI: Intra-Cellular Therapies announced topline results from Study ITI-214-104, a Phase I/II translational study.… https://t.co/HOAw7hpHPN
June 29th 2020, 10:06am
bucksneuro @bucksneuro
RT @BillMiller32: $ITCI Beyond Schizophrenia & Bipolar II(Coming up v.soon), another big positive Top-Line in the Tx of Heart Failure Pts (…
June 29th 2020, 9:06am
SEC_Filings_Now @SEC_Filings_Now
$ITCI: New SEC Filing for $ITCI: Form 8-K (No. 0000950123-20-006465): https://t.co/7XjcEHiWt2
June 29th 2020, 9:06am
bbiittccooiinn @bbiittccooiinn
$ITCI #NASDAQ 8-K - Intra-Cellular Therapies, Inc. [B/A=0/0 - Bid/Ask Size=0/0 Volume=1,161,970 AverageVol=971,… https://t.co/yIxnRiMJRw
June 29th 2020, 9:06am
SwingTradeBot @SwingTradeBot
Recent $ITCI technical alerts: New Uptrend plus 3 more alerts... https://t.co/xs6K8oSF6z
June 29th 2020, 9:06am
MarketCurrents @MarketCurrents
$ITCI - Intra-Cellular's ITI-214 shows positive action in heart failure study https://t.co/BLW29MmOdA
June 29th 2020, 8:06am
Avecousans_TVA @Avecousans_TVA
RT @BioStocks: $ITCI Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Heart Failure
June 29th 2020, 8:06am
BillMiller32 @BillMiller32
$ITCI Beyond Schizophrenia & Bipolar II(Coming up v.soon), another big positive Top-Line in the Tx of Heart Failure… https://t.co/8HdeECmP4N
June 29th 2020, 8:06am
BleugoIG @BleugoIG
$ITCI loving my August $45 covered calls.
June 29th 2020, 8:06am
FlexOniHub @FlexOniHub
$ITCI Wow! Huge Results were Positive! Things are gonna explode there today! all,imo @FlexOniHub
June 29th 2020, 8:06am
Quantumup1 @Quantumup1
RT @portefeuillefun: $ITCI. Intra-Cellular Therapies Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Hea…
June 29th 2020, 8:06am
sbwcws @sbwcws
Intra-Cellular announces top-line results from ITI-214 Phase I/II study $ITCI
June 29th 2020, 8:06am
portefeuillefun @portefeuillefun
$ITCI. Intra-Cellular Therapies Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with… https://t.co/dduP7LlkMM
June 29th 2020, 8:06am
BioStocks @BioStocks
$ITCI Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Heart Failure
June 29th 2020, 8:06am
GrnBulls @GrnBulls
This Week in BioTech: $ITCI is scheduled to release top-line results from Phase 1/2 clinical trial of ITI-214, it… https://t.co/9OZq2P9M2F
June 29th 2020, 6:06am
WeekHerald @WeekHerald
Intra-Cellular Therapies $ITCI Rating Lowered to Hold at Zacks Investment Research https://t.co/IROb8734Bq
June 29th 2020, 2:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.